ArticleOrthopaedic journal of sports medicine2026
Factors Associated With Return to Sport at Minimum 10-Year Follow-up in Athletes With Borderline Hip Dysplasia Undergoing Hip Arthroscopy With Capsular Plication.
Article in Orthopaedic journal of sports medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Literature on long-term return-to-sport (RTS) rates in athletes with borderline hip dysplasia (BHD) is limited. Purpose: To examine patient outcomes and RTS rates in athletes with BHD who underwent primary hip arthroscopy with capsular plication at a minimum 10-year follow-up. Study Design: Cohort study; Level of evidence, 3. Methods: Data were retrospectively reviewed for all patients with BHD (lateral center-edge angle 18°-25°) who underwent primary hip arthroscopy with labral treatment and capsular plication between September 2008 and May 2014. Athletes in the BHD group were propensity matched 1:1 to a control group of patients with normal acetabular coverage based on age, sex, body mass index, follow-up time, Tönnis grade, and preoperative sport competition level. Patient-reported outcome scores (modified Harris Hip Score, Non-Arthritic Hip Score, 12-item International Hip Outcome Tool, Hip Outcome Score Sports Specific Subscale, visual analog scale for pain, and satisfaction), RTS, and continuation-of-sport rates were also analyzed. Results: There were 50 patients (53 hips) in the BHD group and 53 patients (53 hips) in the control group. Both groups demonstrated similar increases in all PROs from preoperative to 10-year follow-up and favorable RTS rates. A total of 46 patients in the BHD group attempted to RTS and 40 (87.0%) were successful while 48 patients in the control group attempted to RTS and 41 (85.4%) were successful at the short to midterm. Of the patients who successfully returned to sport, 28 from the BHD cohort (70.0%) and 30 (73.2%) from the control cohort attempted to continue playing their respective sport 10 years postoperatively. Of these, 23 patients (82.1%) from the BHD cohort and 25 patients (83.3%) from the control cohort successfully continued their sport at a minimum of 10 years postoperatively. Over the course of 10 years of follow-up, 8 patients (16%) out of 50 in the BHD group at some point discontinued their sport, not due to their hip, but because of lifestyle changes or loss of interest. Conclusion: Athletes with BHD who underwent primary hip arthroscopy with capsular plication and labral treatment demonstrated a high rate of RTS at short-term follow-up, high rate of continuation of sport at long-term follow-up, and favorable long-term results. Loss of interest or lifestyle transitions had a greater impact on continuation of sport at long-term follow-up than persistent symptoms related to the hip.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.